Phase 1b ATLAS Study
A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis
Phase 2b MIST Study
A Phase 2b Study Evaluating the Safety and Efficacy of AP01 (inhaled pirfenidone) in Participants With Progressive Pulmonary Fibrosis (PPF)
Learn more about MIST PPF Study